Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Market price (% of par)
-
105.23%
-
Total 13F principal
-
$524,377,000
-
Principal change
-
-$18,705,999
-
Total reported market value
-
$555,941,256
-
Number of holders
-
49
-
Value change
-
-$15,777,248
-
Number of buys
-
21
-
Number of sells
-
19
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 1.750% 6/1 as of Q2 2025
As of 30 Jun 2025,
IONIS PHARMACEUTICALS INC - NOTE 1.750% 6/1 was held by
49 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$524,377,000
in principal (par value) of the bond.
The largest 10 bondholders included
Voya Investment Management LLC, CAMDEN ASSET MANAGEMENT L P /CA, ADVENT CAPITAL MANAGEMENT /DE/, LAZARD ASSET MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, MACKAY SHIELDS LLC, Calamos Advisors LLC, and MORGAN STANLEY.
This page lists
49
institutional bondholders reporting positions
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.